




Searching News Database: insulin glargine
HSMN NewsFeed - 9 Feb 2021
Lannett Expands Strategic Relationship To Include Biosimilar Fast-Acting Insulin
Lannett Expands Strategic Relationship To Include Biosimilar Fast-Acting Insulin
HSMN NewsFeed - 11 Jun 2020
Lannett Provides Update On Clinical Advancement Of Biosimilar Insulin Glargine, Following FDA Meeting
Lannett Provides Update On Clinical Advancement Of Biosimilar Insulin Glargine, Following FDA Meeting
HSMN NewsFeed - 28 Jan 2020
Lilly plans donation of 200,000 insulin KwikPens over next three years to support lower-income communities
Lilly plans donation of 200,000 insulin KwikPens over next three years to support lower-income communities
HSMN NewsFeed - 19 Oct 2018
Mylan and Biocon Announce Positive CHMP Opinion for Ogivri(R), Biosimilar Trastuzumab
Mylan and Biocon Announce Positive CHMP Opinion for Ogivri(R), Biosimilar Trastuzumab
HSMN NewsFeed - 26 Mar 2018
FDA approves inclusion of data from safety outcomes trial in the Tresiba(R) label
FDA approves inclusion of data from safety outcomes trial in the Tresiba(R) label
HSMN NewsFeed - 4 Dec 2015
Samsung Bioepis' RENFLEXIS(R) Infliximab Biosimilar Receives Regulatory Approval in Korea
Samsung Bioepis' RENFLEXIS(R) Infliximab Biosimilar Receives Regulatory Approval in Korea
HSMN NewsFeed - 31 Jan 2014
Eli Lilly and Company Provides Statement in Response to Sanofi U.S. Lawsuit
Eli Lilly and Company Provides Statement in Response to Sanofi U.S. Lawsuit
HSMN NewsFeed - 29 Oct 2008
FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes
FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes
HSMN NewsFeed - 18 Sep 2007
New Data Support Long-Term Efficacy and Safety in Patients Who Took Exubera for Eight Years
New Data Support Long-Term Efficacy and Safety in Patients Who Took Exubera for Eight Years
HSMN NewsFeed - 30 Jul 2007
SoloSTAR(R), the First Prefilled Disposable Insulin Pen for Lantus(R), is Now Available in the United States
SoloSTAR(R), the First Prefilled Disposable Insulin Pen for Lantus(R), is Now Available in the United States
HSMN NewsFeed - 23 Jun 2007
SYMLIN(R) Used in Conjunction with Basal Insulin in Patients with Type 2 Diabetes
SYMLIN(R) Used in Conjunction with Basal Insulin in Patients with Type 2 Diabetes
HSMN NewsFeed - 21 Nov 2006
BYETTA(R) (exenatide) Approved for Treatment of Type 2 Diabetes by European Commission
BYETTA(R) (exenatide) Approved for Treatment of Type 2 Diabetes by European Commission
HSMN NewsFeed - 14 Sep 2006
Study Shows Exenatide Improves Blood Sugar Levels as Effectively as Biphasic Insulin Aspart
Study Shows Exenatide Improves Blood Sugar Levels as Effectively as Biphasic Insulin Aspart
Additional items found! 23

Members Archive contains
23 additional stories matching:
insulin glargine
(Password required)
insulin glargine
(Password required)